Laboratory Testing for Frequent PVCs

Primary Laboratory Evaluation

The American College of Cardiology recommends checking serum potassium, magnesium, and calcium when evaluating patients with prolonged QTc syndrome presenting with PVCs, as electrolyte abnormalities can unmask or worsen arrhythmogenic conditions 1
Laboratory screening should be considered in patients with advanced second or third-degree AV block who also have PVCs, based on echocardiography findings 1
The European Society of Cardiology suggests checking hemoglobin, ferritin, and transferrin saturation in patients with heart failure and PVCs, as iron deficiency can be treated and may impact outcomes 2
Creatinine assessment is relevant in patients with chronic kidney disease who may be receiving contrast studies or undergoing neurohormonal blocker titration 2

The American College of Cardiology recommends echocardiography as the cornerstone initial test to exclude structural heart disease (HCM, DCM, LVNC, ARVC, myocarditis, sarcoidosis) 1, 3, 4
24-hour Holter monitoring is used to quantify PVC burden (>2,000 PVCs/24h carries up to 30% risk of structural disease) 1, 3, 4
Exercise stress testing is used to assess whether PVCs suppress with exercise (benign) or increase (concerning) 1, 3, 4
Cardiac MRI should be performed if >2,000 PVCs or non-sustained VT are present, or if echocardiography is abnormal 1, 3

The American College of Cardiology suggests laboratory electrolyte screening for athletes with prolonged QTc, along with family screening and genetic testing 1
In otherwise healthy young adults with isolated PVCs and normal cardiac structure, routine laboratory testing is not emphasized in the guidelines 4, 5
When multiple PVCs suggest underlying pathology, the evaluation algorithm focuses on imaging (echo, CMR) and rhythm monitoring rather than laboratory studies 1, 3, 4

The American College of Cardiology advises not to delay structural cardiac evaluation to obtain laboratory results, as the primary concern with frequent PVCs is excluding cardiomyopathy, channelopathies, and other structural diseases 1, 3
Thyroid function testing is not specifically mentioned in the PVC guidelines but should be considered based on clinical presentation and general medicine principles 2
Toxicology screening may be warranted if there is suspicion of substance use (stimulants, alcohol) contributing to PVCs, though this is not explicitly detailed in the guidelines 5